This analysis confirmed the underlying variability of clinical phenotype in ILDR1-dependent hearing loss (Kim et al., 2015), and additionally supported the possibility of DFNB42 being a progressive hearing loss disorder (Kim et al., 2015; Sang et al., 2015), successfully treatable by CI. This evidence concerns the gene ILDR1 and hearing loss disorder.